A carregar...
Patient‐Reported Outcomes with PD‐1/PD‐L1 Inhibitors for Advanced Cancer: A Meta‐Analysis
BACKGROUND. The aim of this meta‐analysis was to compare patient‐reported outcomes (PROs) between programmed death receptor‐1/programmed death‐ligand 1 (PD‐1/PD‐L1) inhibitors and standard‐of‐care therapy in patients with advanced cancer. METHODS. We searched randomized controlled trials (RCTs) comp...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6656437/ https://ncbi.nlm.nih.gov/pubmed/30552160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0449 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|